Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: The pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues

Journal of Biological Chemistry

Volumn 289, Issue 24, 2014, Pages 16773-16789

  Nam, Youngpyo ^a   Kim, Jong Heon ^a   Seo, Minchul ^a,e   Kim, Jae Hong ^a   Jin, Myungwon ^a   Jeon, Sangmin ^a,f   Seo, Jung Wan ^a,g   Lee, Won Ha ^b   Bing, So Jin ^c   Jee, Youngheun ^c   Lee, Won Kee ^a   Park, Dong Ho ^a   Kook, Hyun ^d   Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

^c Jeju National University   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e Dongguk University College of Medicine   (South Korea)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Daesang Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; HISTOLOGY; NEUROPHYSIOLOGY; RECOMBINANT PROTEINS; TISSUE;

CENTRAL NERVOUS SYSTEMS; DISEASE DEVELOPMENT; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INFLAMMATORY MEDIATORS; INFLAMMATORY STIMULI; PRO-INFLAMMATORY CYTOKINES; SECONDARY LYMPHOID TISSUE; THERAPEUTIC TARGETS;

CYTOLOGY;

GELATINASE B; INTERLEUKIN 17; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR T BET;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; DNA SEQUENCE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE; GENE EXPRESSION REGULATION; GLIA CELL; IFNG GENE; IL 17A GENE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MICROGLIA; MMP9 GENE; MOUSE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RORC GENE; T CELL CULTURE; T LYMPHOCYTE ACTIVATION; TBET GENE; UPREGULATION;

ASTROCYTE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; EAE; LCN2; MICROGLIA; MULTIPLE SCLEROSIS; NEUROINFLAMMATION;

ACUTE-PHASE PROTEINS; ANIMALS; ASTROCYTES; CELLS, CULTURED; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE DELETION; INTERFERON-GAMMA; INTERLEUKIN-17; LIPOCALINS; LYMPHOID TISSUE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MYELIN SHEATH; NEUTROPHILS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; SPINAL CORD; T-LYMPHOCYTES;

EID: 84902477342     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.542282     Document Type: Article

References (81)

1. Frohman, E. M., Racke, M. K., and Raine, C. S. (2006) Multiple sclerosis: the plaque and its pathogenesis. N. Engl. J. Med. 354, 942-955
2. Man, S., Ubogu, E. E., and Ransohoff, R. M. (2007) Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol. 17, 243-250 (Pubitemid 46466143)
3. McFarland, H. F., and Martin, R. (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913-919 (Pubitemid 47300005)
4. Dutta, R., and Trapp, B. D. (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 68, S22-S31; discussion S43-S54
5. Sospedra, M., and Martin, R. (2005) Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683-747 (Pubitemid 40563183)
6. Pettinelli, C. B., and McFarlin, D. E. (1981) Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J. Immunol. 127, 1420-1423 (Pubitemid 11021014)
7. Zamvil, S. S., and Steinman, L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8, 579-621 (Pubitemid 20135640)
8. Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Ohlén, C., and Goverman, J. (2001) A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194, 669-676 (Pubitemid 32844776)
9. Archelos, J. J., Storch, M. K., and Hartung, H. P. (2000) The role of B cells and autoantibodies in multiple sclerosis. Ann. Neurol. 47, 694-706 (Pubitemid 30390190)
10. Genain, C. P., Cannella, B., Hauser, S. L., and Raine, C. S. (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5, 170-175 (Pubitemid 29068523)
11. Esiri, M. M. (1977) Immunoglobulin-containing cells in multiple-sclerosis plaques. Lancet 2, 478
12. Sayed, B. A., Walker, M. E., and Brown, M. A. (2011) Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis. J. Immunol. 186, 3294-3298
13. Zappulla, J. P., Arock, M., Mars, L. T., and Liblau, R. S. (2002) Mast cells: new targets for multiple sclerosis therapy? J. Neuroimmunol. 131, 5-20
14. Dijkstra, C. D., De Groot, C. J., and Huitinga, I. (1992) The role of macrophages in demyelination. J. Neuroimmunol. 40, 183-188
15. Kang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R. M., Bergmann, C., Stohlman, S., Tuohy, V. K., and Li, X. (2010) Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32, 414-425
16. Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., Becher, B., and Aguzzi, A. (2005) Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11, 146-152 (Pubitemid 40321349)
17. Wang, Y., Kai, H., Chang, F., Shibata, K., Tahara-Hanaoka, S., Honda, S., Shibuya, A., and Shibuya, K. (2007) A critical role of LFA-1 in the development of Th17 cells and induction of experimental autoimmune encephalomyelytis. Biochem. Biophys. Res. Commun. 353, 857-862 (Pubitemid 46080376)
18. Bullard, D. C., Hu, X., Schoeb, T. R., Collins, R. G., Beaudet, A. L., and Barnum, S. R. (2007) Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis. J. Immunol. 178, 851-857 (Pubitemid 46095157)
19. Zhang, G. X., Baker, C. M., Kolson, D. L., and Rostami, A. M. (2000) Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis. Mult. Scler. 6, 3-13 (Pubitemid 30175365)
20. Tran, E. H., Prince, E. N., and Owens, T. (2000) IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164, 2759-2768 (Pubitemid 30115510)
21. Hraba-Renevey, S., Türler, H., Kress, M., Salomon, C., and Weil, R. (1989) SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 4, 601-608 (Pubitemid 19139712)
22. Liu, Q., and Nilsen-Hamilton, M. (1995) Identification of a new acute phase protein. J. Biol. Chem. 270, 22565-22570
23. Cowland, J. B., and Borregaard, N. (1997) Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45, 17-23 (Pubitemid 27449379)
24. Akerstrom, B., Flower, D. R., and Salier, J. P. (2000) Lipocalins: unity in diversity. Biochim. Biophys. Acta 1482, 1-8
25. Flower, D. R. (1996) The lipocalin protein family: structure and function. Biochem. J. 318, 1-14
26. Flower, D. R. (1994) The lipocalin protein family: a role in cell regulation. FEBS Lett. 354, 7-11
27. Bauer, M., Eickhoff, J. C., Gould, M. N., Mundhenke, C., Maass, N., and Friedl, A. (2008) Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res. Treat. 108, 389-397 (Pubitemid 351431077)
28. Devireddy, L. R., Gazin, C., Zhu, X., and Green, M. R. (2005) A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123, 1293-1305 (Pubitemid 41821786)
29. Tong, Z., Wu, X., Ovcharenko, D., Zhu, J., Chen, C. S., and Kehrer, J. P. (2005) Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem. J. 391, 441-448 (Pubitemid 41532443)
30. Yang, J., Goetz, D., Li, J. Y., Wang, W., Mori, K., Setlik, D., Du, T., Erdjument-Bromage, H., Tempst, P., Strong, R., and Barasch, J. (2002) An iron delivery pathway mediated by a lipocalin. Mol. Cell 10, 1045-1056 (Pubitemid 35453824)
31. Nielsen, B. S., Borregaard, N., Bundgaard, J. R., Timshel, S., Sehested, M., and Kjeldsen, L. (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 38, 414-420
32. Nomura, I., Gao, B., Boguniewicz, M., Darst, M. A., Travers, J. B., and Leung, D. Y. (2003) Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J. Allergy Clin. Immunol. 112, 1195-1202 (Pubitemid 37550015)
33. Katano, M., Okamoto, K., Arito, M., Kawakami, Y., Kurokawa, M. S., Suematsu, N., Shimada, S., Nakamura, H., Xiang, Y., Masuko, K., Nishioka, K., Yudoh, K., and Kato, T. (2009) Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res. Ther. 11, R3
34. Javierre, B. M., Fernandez, A. F., Richter, J., Al-Shahrour, F., Martin-Subero, J. I., Rodriguez-Ubreva, J., Berdasco, M., Fraga, M. F., O'Hanlon, T. P., Rider, L. G., Jacinto, F. V., Lopez-Longo, F. J., Dopazo, J., Forn, M., Peinado, M. A., Carreño, L., Sawalha, A. H., Harley, J. B., Siebert, R., Esteller, M., Miller, F. W., and Ballestar, E. (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 20, 170-179
35. Shen, F., Hu, Z., Goswami, J., and Gaffen, S. L. (2006) Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem. 281, 24138-24148 (Pubitemid 44274188)
36. Shen, F., Ruddy, M. J., Plamondon, P., and Gaffen, S. L. (2005) Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-α-induced genes in bone cells. J. Leukoc. Biol. 77, 388-399 (Pubitemid 40289569)
37. Choi, J., Lee, H. W., and Suk, K. (2011) Increased plasma levels of lipocalin 2 in mild cognitive impairment. J. Neurol. Sci. 305, 28-33
38. Naudé, P. J., Nyakas, C., Eiden, L. E., Ait-Ali, D., van der Heide, R., Engelborghs, S., Luiten, P. G., De Deyn, P. P., den Boer, J. A., and Eisel, U. L. (2012) Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J. 26, 2811-2823
39. Tong, J., Huang, C., Bi, F., Wu, Q., Huang, B., Liu, X., Li, F., Zhou, H., and Xia, X. G. (2013) Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 32, 1917-1926
40. Bi, F., Huang, C., Tong, J., Qiu, G., Huang, B., Wu, Q., Li, F., Xu, Z., Bowser, R., Xia, X. G., and Zhou, H. (2013) Reactive astrocytes secrete lcn2 to promote neuron death. Proc. Natl. Acad. Sci. U.S.A. 110, 4069-4074
41. Lee, S., Park, J. Y., Lee, W. H., Kim, H., Park, H. C., Mori, K., and Suk, K. (2009) Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 29, 234-249
42. Lee, S., Kim, J. H., Kim, J. H., Seo, J. W., Han, H. S., Lee, W. H., Mori, K., Nakao, K., Barasch, J., and Suk, K. (2011) Lipocalin-2 is a chemokine inducer in the central nervous system: role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration. J. Biol. Chem. 286, 43855-43870
43. Jang, E., Lee, S., Kim, J. H., Kim, J. H., Seo, J. W., Lee, W. H., Mori, K., Nakao, K., and Suk, K. (2013) Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J. 27, 1176-1190
44. Ip, J. P., Noçon, A. L., Hofer, M. J., Lim, S. L., Müller, M., and Campbell, I. L. (2011) Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. J. Neuroinflammation 8, 124
45. Chia, W. J., Dawe, G. S., and Ong, W. Y. (2011) Expression and localization of the iron-siderophore binding protein lipocalin 2 in the normal rat brain and after kainate-induced excitotoxicity. Neurochem. Int. 59, 591-599
46. Rathore, K. I., Berard, J. L., Redensek, A., Chierzi, S., Lopez-Vales, R., Santos, M., Akira, S., and David, S. (2011) Lipocalin 2 plays an immunomodulatory role and has detrimental effects after spinal cord injury. J. Neurosci. 31, 13412-13419
47. Lee, S., Lee, W. H., Lee, M. S., Mori, K., and Suk, K. (2012) Regulation by lipocalin-2 of neuronal cell death, migration, and morphology. J. Neurosci. Res. 90, 540-550
48. Mucha, M., Skrzypiec, A. E., Schiavon, E., Attwood, B. K., Kucerova, E., and Pawlak, R. (2011) Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc. Natl. Acad. Sci. U.S.A. 108, 18436-18441
49. Nairz, M., Theurl, I., Schroll, A., Theurl, M., Fritsche, G., Lindner, E., Seifert, M., Crouch, M. L., Hantke, K., Akira, S., Fang, F. C., and Weiss, G. (2009) Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114, 3642-3651
50. Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., and Aderem, A. (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917-921 (Pubitemid 40037155)
51. Jiang, H. R., Al Rasebi, Z., Mensah-Brown, E., Shahin, A., Xu, D., Goodyear, C. S., Fukada, S. Y., Liu, F. T., Liew, F. Y., and Lukic, M. L. (2009) Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J. Immunol. 182, 1167-1173
52. Flügel, A., Berkowicz, T., Ritter, T., Labeur, M., Jenne, D. E., Li, Z., Ellwart, J. W., Willem, M., Lassmann, H., and Wekerle, H. (2001) Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14, 547-560 (Pubitemid 32520866)
53. Zamanian, J. L., Xu, L., Foo, L. C., Nouri, N., Zhou, L., Giffard, R. G., and Barres, B. A. (2012) Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391-6410
54. Lin, Y., Roberts, T. J., Sriram, V., Cho, S., and Brutkiewicz, R. R. (2003) Myeloid marker expression on antiviral CD8+ T cells following an acute virus infection. Eur. J. Immunol. 33, 2736-2743 (Pubitemid 37337139)
55. Lee, S., Lee, J., Kim, S., Park, J. Y., Lee, W. H., Mori, K., Kim, S. H., Kim, I. K., and Suk, K. (2007) A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J. Immunol. 179, 3231-3241
56. Jeon, S., Jha, M. K., Ock, J., Seo, J., Jin, M., Cho, H., Lee, W. H., and Suk, K. (2013) Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury. J. Biol. Chem. 288, 24116-24127
57. Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., and Gage, F. H. (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934
58. Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A., and Goverman, J. M. (2008) Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14, 337-342 (Pubitemid 351347910)
59. Cornet, A., Bettelli, E., Oukka, M., Cambouris, C., Avellana-Adalid, V., Kosmatopoulos, K., and Liblau, R. S. (2000) Role of astrocytes in antigen presentation and naive T-cell activation. J. Neuroimmunol. 106, 69-77 (Pubitemid 30256079)
60. Panek, R. B., Lee, Y. J., Itoh-Lindstrom, Y., Ting, J. P., and Benveniste, E. N. (1994) Characterization of astrocyte nuclear proteins involved in IFN-γ- and TNF-α-mediated class II MHC gene expression. J. Immunol. 153, 4555-4564 (Pubitemid 24346850)
61. Simpson, J., Rezaie, P., Newcombe, J., Cuzner, M. L., Male, D., and Woodroofe, M. N. (2000) Expression of the β-chemokine receptors CCR2, CCR3, and CCR5 in multiple sclerosis central nervous system tissue. J. Neuroimmunol. 108, 192-200 (Pubitemid 30438767)
62. Van Der Voorn, P., Tekstra, J., Beelen, R. H., Tensen, C. P., Van Der Valk, P., and De Groot, C. J. (1999) Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am. J. Pathol. 154, 45-51 (Pubitemid 29031610)
63. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., and Tuohy, V. K. (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7, 592-600 (Pubitemid 23120908)
64. Gijbels, K., Masure, S., Carton, H., and Opdenakker, G. (1992) Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 41, 29-34
65. Gijbels, K., Galardy, R. E., and Steinman, L. (1994) Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94, 2177-2182 (Pubitemid 24379586)
66. Yan, L., Borregaard, N., Kjeldsen, L., and Moses, M. A. (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J. Biol. Chem. 276, 37258-37265
67. Tschesche, H., Zölzer, V., Triebel, S., and Bartsch, S. (2001) The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. Eur. J. Biochem. 268, 1918-1928 (Pubitemid 32852933)
68. Yong, V. W., Power, C., Forsyth, P., and Edwards, D. R. (2001) Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511 (Pubitemid 33676585)
69. Crocker, S. J., Whitmire, J. K., Frausto, R. F., Chertboonmuang, P., Soloway, P. D., Whitton, J. L., and Campbell, I. L. (2006) Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1- deficient mice. Am. J. Pathol. 169, 2104-2116 (Pubitemid 351181970)
70. Summers, C., Rankin, S. M., Condliffe, A. M., Singh, N., Peters, A. M., and Chilvers, E. R. (2010) Neutrophil kinetics in health and disease. Trends Immunol. 31, 318-324
71. Puga, I., Cols, M., Barra, C. M., He, B., Cassis, L., Gentile, M., Comerma, L., Chorny, A., Shan, M., Xu, W., Magri, G., Knowles, D. M., Tam, W., Chiu, A., Bussel, J. B., Serrano, S., Lorente, J. A., Bellosillo, B., Lloreta, J., Juanpere, N., Alameda, F., Baró, T., de Heredia, C. D., Torán, N., Català, A., Torrebadell, M., Fortuny, C., Cusí, V., Carreras, C., Diaz, G. A., Blander, J. M., Farber, C. M., Silvestri, G., Cunningham-Rundles, C., Calvillo, M., Dufour, C., Notarangelo, L. D., Lougaris, V., Plebani, A., Casanova, J. L., Ganal, S. C., Diefenbach, A., Aróstegui, J. I., Juan, M., Yagüe, J., Mahlaoui, N., Donadieu, J., Chen, K., and Cerutti, A. (2012) B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat. Immunol. 13, 170-180
72. Soehnlein, O. (2009) An elegant defense: how neutrophils shape the immune response. Trends Immunol. 30, 511-512
73. van Gisbergen, K. P., Sanchez-Hernandez, M., Geijtenbeek, T. B., and van Kooyk, Y. (2005) Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J. Exp. Med. 201, 1281-1292 (Pubitemid 40629071)
74. Berard, J. L., Zarruk, J. G., Arbour, N., Prat, A., Yong, V. W., Jacques, F. H., Akira, S., and David, S. (2012) Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia 60, 1145-1159
75. Marques, F., Mesquita, S. D., Sousa, J. C., Coppola, G., Gao, F., Geschwind, D. H., Columba-Cabezas, S., Aloisi, F., Degn, M., Cerqueira, J. J., Sousa, N., Correia-Neves, M., and Palha, J. A. (2012) Lipocalin 2 is present in the EAE brain and is modulated by natalizumab. Front. Cell. Neurosci. 6, 33
76. Hawlisch, H., Wills-Karp, M., Karp, C. L., and Köhl, J. (2004) The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol. Immunol. 41, 123-131 (Pubitemid 38668621)
77. Köhl, J. (2006) Self, non-self, and danger: a complementary view. Adv. Exp. Med. Biol. 586, 71-94
78. Szalai, A. J., Hu, X., Adams, J. E., and Barnum, S. R. (2007) Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease. Mol. Immunol. 44, 3132-3136 (Pubitemid 46610512)
79. Nataf, S., Carroll, S. L., Wetsel, R. A., Szalai, A. J., and Barnum, S. R. (2000) Attenuation of experimental autoimmune demyelination in complementdeficient mice. J. Immunol. 165, 5867-5873
80. Luchtefeld, M., Preuss, C., Rühle, F., Bogalle, E. P., Sietmann, A., Figura, S., Müller, W., Grote, K., Schieffer, B., and Stoll, M. (2011) Gp130-dependent release of acute phase proteins is linked to the activation of innate immune signaling pathways. PLoS ONE 6, e19427
81. Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P., Stritesky, G. L., Kaplan, M. H., Waisman, A., Kuchroo, V. K., and Oukka, M. (2008) IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. U.S.A. 105, 18460-18465